✦ LIBER ✦

Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors

✍ Scribed by Chuansumrit, A.; Sirachainan, N.; Panuwannakorn, M.; Wongwerawattanakoon, P.; Kadegasem, P.; Choeyprasert, W.; Sasanakul, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary prophylaxis with recombinant a

✍ W. K. HOOTS; L. S. EBBESEN; B. A. KONKLE; G. K.-H. AUERSWALD; H. R. ROBERTS; J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

PSY27 THE LONG-TERM COST OF ORTHOPAEDIC

✍ Å Ericsson; M Haglund 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

On-demand treatment of bleeds in haemoph

✍ B. SØRENSEN; Y. DARGAUD; G. KENET; J. LUSHER; A. MUMFORD; S. PIPE; A. TIEDE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Efficacy of recombinant activated factor

✍ M. J. TREUR; F. MCCRACKEN; B. HEEG; A. V. JOSHI; M. F. BOTTEMAN; F. DE CHARRO; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Prophylaxis with recombinant factor VIIa

✍ J. BLATNY; S. KOHLEROVA; O. ZAPLETAL; V. FIAMOLI; M. PENKA; O. SMITH 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Recombinant activated factor VII safety

✍ C. NAKAR; D. L. COOPER; D. DiMICHELE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB